Skip to main content
SpringerLink
Log in

Special Problems in Caring for Patients on Peritoneal Dialysis

  • Chapter
  • First Online:
Core Concepts in Dialysis and Continuous Therapies

  • 1709 Accesses

Abstract

This chapter deals with challenges concerning the treatment of patients on peritoneal dialysis (PD). Changes in peritoneal transport characteristics with time and decreasing ultrafiltration capacity is a frequent complication in PD patients, which may result in fluid overload. Protein-energy wasting is common in PD patients and needs careful evaluation and treatment. Diabetic PD patients need special attention because of the continuous glucose absorption from the dialysate, which may contribute to poor metabolic control. The glucose absorption may also contribute to obesity and an atherogenic lipid profile. This chapter reviews these issues and summarizes the treatment options concerning these problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Heimbürger O. Peritoneal physiology. In: Pereira BJG, Sayegh MH, Blake P, editors. Chronic kidney disease, dialysis and transplantation: a companion to brenner and rector’s the kidney. ed 2. Philadelphia: Elsevier Saunders; 2005. p. 491–513.

    Chapter  Google Scholar 

  2. Rippe B, Rosengren BI, Venturoli D. The peritoneal microcirculation in peritoneal dialysis. Microcirculation. 2001;8:303–20.

    Article  CAS  PubMed  Google Scholar 

  3. Flessner MF. Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol. 1991;2:122–35.

    CAS  PubMed  Google Scholar 

  4. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. Peritonealequilibration test. Perit Dial Bull. 1987;7:138–47.

    Google Scholar 

  5. Haraldsson B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int. 1995;47:1187–98.

    Article  CAS  PubMed  Google Scholar 

  6. Vonesh EP, Lysaght MJ, Moran J, Farrell P. Kinetic modeling as a prescription aid in peritoneal dialysis. Blood Purif. 1991;9:246–70.

    Article  CAS  PubMed  Google Scholar 

  7. Vonesh EF, Rippe B. Net fluid absorption under membrane transport models of peritoneal dialysis. Blood Purif. 1992;10:209–26.

    Article  CAS  PubMed  Google Scholar 

  8. van Biesen W, Heimburger O, Krediet R, Rippe B, Lamilia V, Covic A, Vanholder R, ERBP working group on peritoneal dialysis. Evaluation of peritoneal membrane characteristics: a clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant. 2010;25:2052–62.

    Article  PubMed  Google Scholar 

  9. Mujais S, Nolph KD, Gokal R, Blake P, Burkhart J, Coles G, Kawaguchi Y, Kawanishi H, Korbet S, Krediet RT, Lindholm B, Oreopoulos DG, Rippe B, Selgas R. International society of peritoneal dialysis ad hoc committee on ultrafiltration management in peritoneal dialysis: evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int. 2000;20(Suppl 4):S5–21.

    PubMed  Google Scholar 

  10. Heimbürger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int. 1990;38:495–506.

    Article  PubMed  Google Scholar 

  11. Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int. 1997;17:144–50.

    CAS  PubMed  Google Scholar 

  12. Waniewski J, Heimbürger O, Werynski A, Lindholm B. Osmotic conductance of the peritoneum in CAPD patients with permanent loss of ultrafiltration capacity. Perit Dial Int. 1996;16:488–96.

    Google Scholar 

  13. Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21:1077–85.

    Article  CAS  PubMed  Google Scholar 

  14. Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int. 2013;84:969–79.

    Article  CAS  PubMed  Google Scholar 

  15. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MWY, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D, balANZ Trial Investigators. The effect of low glucose degradation product, neutral pH vs. standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol Dial Transplant. 2012;27:4445–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.

    Article  CAS  PubMed  Google Scholar 

  17. van Biesen W, Claes K, Covic A, Fan S, Lichodziejewska-Niemierko M, Schoder V, Verger C, Wabel P. A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrol Dial Transplant. 2013;28:2620–8.

    Article  PubMed  Google Scholar 

  18. Carrero JJ, Heimbürger O, Chan M, Axelsson J, Sternvinkel P, Lindholm B. Protein-energy malnutrition/wasting during peritoneal dialysis (Chapter 12). In: Khanna R, Krediet RT, editors. Nolph and Gokal’s textbook of peritoneal dialysis. 3rd ed. New York: Springer; 2009.

    Google Scholar 

  19. Stratton RJ, Bircher G, Fouque D, Stenvinkel P, de Mutsert R, Engfer M, Elia M. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2005;46:387–405.

    Article  CAS  PubMed  Google Scholar 

  20. Jones MR, Gehr TW, Burkart JM, Hamburger RJ, Kraus AP Jr, Piraino BM, Hagen T, Ogrinc FG, Wolfson M. Replacement of amino acid and protein losses with 1.1 % amino acid peritoneal dialysis solution. Perit Dial Int. 1998;18:210–6.

    CAS  PubMed  Google Scholar 

  21. Kopple JD, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47:1148–57.

    Article  CAS  PubMed  Google Scholar 

  22. Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, Chan TM. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42:173–83.

    Article  CAS  PubMed  Google Scholar 

  23. Szeto CC, Wong TY, Chow KM, Leung CB, Wang AY, Lui SF, Li PK. The impact of increasing the daytime dialysis exchange frequency on peritoneal dialysis adequacy and nutritional status of Chinese anuric patients. Perit Dial Int. 2002;22:197–203.

    PubMed  Google Scholar 

  24. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol 2003;14:2119–26.

    Article  CAS  PubMed  Google Scholar 

  25. Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C, International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the international society of renal nutrition and metabolism. Kidney Int. 2013;84:1096–107.

    Article  CAS  PubMed  Google Scholar 

  26. UNITED STATES RENAL DATA SYSTEM Annual Data Report. 2014. www.usrds.org.

  27. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, Ma JZ. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34:1065–74.

    Article  CAS  PubMed  Google Scholar 

  28. Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O. Van Biesen W, European Renal Best Practice (ERBP) Diabetes Guideline Development Group. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant. 2014;30(2):310–20. pii: gfu293. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  29. Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, Drechsler C, Lacatus R, Vanholder R, Nistor I, European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. 2014;29:2167–77.

    Article  PubMed  Google Scholar 

  30. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, Kalantar-Zadeh K. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011;6:1041–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Adler A, Casula A, Steenkamp R, Fogarty D, Wilkie M, Tomlinson L, Nitsch D, Roderick P, Tomson CR. Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K. Diabetes Care. 2014;37:1304–11.

    Article  CAS  PubMed  Google Scholar 

  32. ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–28.

    Article  CAS  PubMed  Google Scholar 

  33. Rodríguez-Carmona A, Pérez-Fontán M, López-Muñiz A, Ferreiro-Hermida T, García-Falcón T. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis. Perit Dial Int. 2014;34:618–26.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Szeto CC, Chow KM, Leung CB, Kwan BC, Chung KY, Law MC, Li PK. Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis. Nephrol Dial Transplant. 2007;22:1697–702.

    Article  CAS  PubMed  Google Scholar 

  35. Arnouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J, van Biesen W. Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties. Nephrol Dial Transplant. 2014;29:1284–300.

    Article  CAS  PubMed  Google Scholar 

  36. Al-Hwiesh AK, Abdul-Rahman IS, El-Deen MA, Larbi E, Divino-Filho JC, Al-Mohanna FA, Gupta KL. Metformin in peritoneal dialysis: a pilot experience. Perit Dial Int. 2014;34:368–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–20.

    CAS  PubMed  Google Scholar 

  38. Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int. 2003;64:1480–6.

    Article  PubMed  Google Scholar 

  39. Paniagua R, Ventura MD, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong MD, García-González Z, Villanueva D, Orihuela O, Prado-Uribe MD, Alcántara G, Amato D. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009;29:422–32.

    CAS  PubMed  Google Scholar 

  40. Li PK, Culleton BF, Ariza A, Do JY, Johnson DW, Sanabria M, Shockley TR, Story K, Vatazin A, Verrelli M, Yu AW, Bargman JM, IMPENDIA and EDEN Study Groups. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol. 2013;24:1889–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Tsai CY, Lee SC, Hung CC, Lee JJ, Kuo MC, Hwang SJ, Chen HC. False elevation of blood glucose levels measured by GDH-PQQ-based glucometers occurs during all daily dwells in peritoneal dialysis patients using icodextrin. Perit Dial Int. 2010;30:329–35.

    Article  CAS  PubMed  Google Scholar 

  42. Wolf C, Tanner M. Obesity. West J Med. 2002;176:23–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P. Serum-immunoreactive leptin concentration and its relation to body fat content in chronic renal failure. J Am Soc Nephrol. 1997;8:1423–30.

    PubMed  Google Scholar 

  44. Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JGP, Krediet RT, NECOSAD Study Group. Nutritional status over time in haemodialysis and peritoneal dialysis. J Am Soc Nephrol. 2001;12:1272–9.

    CAS  PubMed  Google Scholar 

  45. Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimbürger O. Increases in serum leptin during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol. 2000;11:1303–9.

    CAS  PubMed  Google Scholar 

  46. Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG. Excessive weight gain during peritoneal dialysis. Int J Artif Organs. 2001;24:197–202.

    CAS  PubMed  Google Scholar 

  47. Heimbürger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int. 1992;41:1320–32.

    Article  PubMed  Google Scholar 

  48. Nordfors L, Heimbürger O, Lönnqvist F, Lindholm B, Helmrich J, Schalling M, Stenvinkel P. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int. 2000;57:1713–9.

    Article  CAS  PubMed  Google Scholar 

  49. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients. Clin Nephrol. 1996;45:194–8.

    CAS  PubMed  Google Scholar 

  50. Yanowski JA, Yanowski SZ. Recent advances in basic obesity research. JAMA. 1999;282:1504–6.

    Article  Google Scholar 

  51. Fernström A, Hylander B, Å M, Jacobsson H, Rössner S. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int. 1998;18:166–71.

    PubMed  Google Scholar 

  52. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808.

    Article  PubMed  Google Scholar 

  53. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Cruess DF, Kimmel PL. Body mass index, dialysis modality, and survival: analysis of the United States renal data system dialysis morbidity and mortality wave II study. Kidney Int. 2004;65:597–605.

    Article  PubMed  Google Scholar 

  54. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003;14:2894–901.

    Article  PubMed  Google Scholar 

  55. Piraino B, Bernardini J, Centa PK, Johnston JR, Sorkin M. The effect of body weight on CAPD related infections and catheter loss. Perit Dial Int. 1991;11:64–8.

    CAS  PubMed  Google Scholar 

  56. Crabtree JH, Burchette RJ. Comparative analysis of two-piece extended peritoneal dialysis catheters with remote exit-site locations and conventional abdominal catheters. Perit Dial Int. 2010;30:46–55.

    Article  PubMed  Google Scholar 

  57. Johansson AC, Samuelsson O, Attman PO, Bosaeus I, Haraldsson B. Limitations in anthropometric calculations of total body water in patients on peritoneal dialysis. J Am Soc Nephrol. 2001;12:568–73.

    CAS  PubMed  Google Scholar 

  58. Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int. 2003;23:276–83.

    PubMed  Google Scholar 

  59. Gokal R, Moberly J, Lindholm B, Mujais S. Metabolic and laboratory effects of icodextrin. Kidney Int. 2002;62 Suppl 81:62–71.

    Article  Google Scholar 

  60. Wolfson M, Piraino B, Hamburger RJ, Morton AR, Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis. 2002;40:1055–65.

    Article  CAS  PubMed  Google Scholar 

  61. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimbürger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14:2338–44.

    Article  CAS  PubMed  Google Scholar 

  62. Prichard SS. Management of hyperlipidemia in patients on peritoneal dialysis: current approaches. Kidney Int 2006(suppl 103):S115–7.

    Google Scholar 

  63. Epstein M, Vaziri ND. Statins in the management of dyslipidemia associated with chronic kidney disease. Nat Rev Nephrol. 2012;8:214–23.

    Article  CAS  PubMed  Google Scholar 

  64. Heimbürger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Nephron. 1996;72:135–44.

    Article  PubMed  Google Scholar 

  65. Liu Y, Coresh J, Eustace JA, Longnecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients. Role of inflammation and malnutrition. JAMA. 2004;291:451–9.

    Article  CAS  PubMed  Google Scholar 

  66. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009;15(2):CD004289.

    Google Scholar 

  67. Wanner C, Krane V, März W, Olschewski M, Mann J, Ruf G, Ritz E. German diabetes and dialysis study investigators: atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–48.

    Article  CAS  PubMed  Google Scholar 

  68. März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C, German Diabetes and Dialysis Study Investigators. Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol. 2011;6:1316–25.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F, AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395–407.

    Article  PubMed  Google Scholar 

  70. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R, SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Goldfarb-Rumyantzev AS, Habib AN, Baird BC, Barenbaum LL, Cheung AK. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis. Am J Kidney Dis. 2007;50:791–802.

    Article  CAS  PubMed  Google Scholar 

  72. Lee JE, Oh K-H, Choi KH, Kim SB, Kim Y-S, Do J-Y, Kim Y-L, Kim DJ. Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison. Nephrol Dial Transplant. 2011;26:4090–4.

    Article  CAS  PubMed  Google Scholar 

  73. Heimburger O. Lipid disorders, statins and the peritoneal membrane. Contrib Nephrol. 2009;163:177–82.

    Article  PubMed  Google Scholar 

  74. Sniderman AD, Sloand JA, Li PK, Story K, Bargman JM. Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials. J Clin Lipidol. 2014;8:441–7.

    Article  PubMed  Google Scholar 

  75. Prestidge C, Ronaldson J, Wong W, Stack M, Kara T. Infectious outcomes following gastrostomy in children receiving peritoneal dialysis. Pediatr Nephrol. 2015;30:849–54. [Epub ahead of print].

    Google Scholar 

  76. Dahlan R, Biyani M, McCormick BB. High mortality following gastrostomy tube insertion in adult peritoneal dialysis patients: case report and literature review. Endoscopy. 2013;45(Suppl 2) UCTN:E313–4.

    Google Scholar 

  77. Paudel K, Fan SL. Successful use of continuous ambulatory peritoneal dialysis in 2 adults with a gastrostomy. Am J Kidney Dis. 2014;64:316–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

    Assoc. Prof. Olof Heimbürger MD, PhD

Authors
  1. Assoc. Prof. Olof Heimbürger MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olof Heimbürger MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Nephrology, Beaumont Hospital, Dublin, Dublin, Ireland

    Colm C. Magee

  2. Department of Medicine/Renal Division, Brigham and Women's Hospital, BOSTON, Massachusetts, USA

    J. Kevin Tucker

  3. Global and Continuing Education, Harvard Medical School, Boston, Massachusetts, USA

    Ajay K. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Heimbürger, O. (2016). Special Problems in Caring for Patients on Peritoneal Dialysis. In: Magee, C., Tucker, J., Singh, A. (eds) Core Concepts in Dialysis and Continuous Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7657-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7657-4_12

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7655-0

  • Online ISBN: 978-1-4899-7657-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation